<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[AtriCure, Inc. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=26475></link><description><![CDATA[AtriCure, Inc. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 16 May 2026 05:15:07 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2016/01/3554153577_20160120135458_8103401401.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[AtriCure Announces Approval for the AtriClip in Japan]]></title><link>https://www.newswire.co.kr/newsRead.php?no=815633</link><description><![CDATA[WEST CHESTER, Ohio--(Business Wire/Korea Newswire)--AtriCure, Inc.  (Nasdaq: ATRC) , a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its AtriClip™ products, which includes the AtriClip™ Standard and the AtriClip Pro™ devices....]]></description><pubDate>Wed, 20 Jan 2016 15:00:00 +0900</pubDate></item><item><title><![CDATA[아트리큐어, 일본에서 아트리클립 승인 발표]]></title><link>https://www.newswire.co.kr/newsRead.php?no=815635</link><description><![CDATA[웨스트체스터, 오하이오--(Business Wire/뉴스와이어)--심방세동(Afib) 및 좌심방부속기(LAA) 관리를 위한 치료기 분야의 대표적인 혁신업체인 아트리큐어(AtriCure, Inc. )(나스닥: ATRC)가 오늘 일본 후생노동성(Ministry of Health, Labor and Welfare, 이하 MHLW)이 아트리클립 스탠다드(AtriClip™ Standard) 및 아트리클립 프로(AtriClip Pro™) 기기를 포함한 자사의 아트리클립(AtriClip™) 제품들을 승인했다고 발표했다.  ...]]></description><pubDate>Wed, 20 Jan 2016 15:00:00 +0900</pubDate></item></channel></rss>